Related Experiment Video
Updated: Apr 16, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Autoimmune polyglandular syndrome type II - a case report
A K Azad1, M S Islam, S L Quayum
1Dr Md Abul Kalam Azad, Associate Professor, Department of Medicine, Bangabandhu Sheikh Mujib Medical University, Shahbagh, Dhaka, Bangladesh.
Autoimmune Polyendocrine Syndrome (APS) type II, typically seen in middle-aged women, can occur in children. This case highlights APS type II in a 14-year-old girl with Addison's disease and other autoimmune conditions.
Area of Science:
- Endocrinology
- Immunology
- Pediatrics
Background:
- Autoimmune Polyendocrine Syndrome (APS) type II is an endocrine disorder characterized by Addison's disease, autoimmune thyroid disease, and/or type I diabetes mellitus.
- While more common in middle-aged females, APS type II is considered rare in pediatric populations.
Observation:
- A 14-year-old female presented with a rare pediatric manifestation of APS type II.
- The patient exhibited concurrent diagnoses of Addison's disease, autoimmune hypothyroidism, and primary hypogonadism.
Findings:
- This case underscores the importance of considering APS type II in pediatric patients, irrespective of typical demographic profiles.
- The co-occurrence of multiple autoimmune conditions in a young patient warrants thorough investigation for APS type II.
Implications:
- Early diagnosis and management of APS type II in children can prevent severe complications associated with hormone deficiencies.
- This case expands the understanding of APS type II presentation, emphasizing its occurrence across a wider age spectrum.
- Healthcare providers should maintain a high index of suspicion for APS type II in children presenting with Addison's disease or other autoimmune endocrine disorders.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
10:52Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...